# FDA Inspection 1262160 - Eagle Pharma Outsourcing LLC - February 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/eagle-pharma-outsourcing-llc/80b99a47-cb5e-4f94-a3fc-f5fff43c4070
Source feed: FDA_Inspections

> FDA Inspection 1262160 for Eagle Pharma Outsourcing LLC on February 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262160
- Company Name: Eagle Pharma Outsourcing LLC
- Inspection Date: 2025-02-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 1149844 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/eagle-pharma-outsourcing-llc/86ac9ff4-281e-460a-ab50-38f8738b9a0a)
- [FDA Inspection 1053615 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/eagle-pharma-outsourcing-llc/df1c1951-3c3a-433f-8e0d-97bc6142ee36)
- [FDA Inspection 942734 - 2015-08-21](https://www.keypedia.com/records/fda_inspections/eagle-pharma-outsourcing-llc/82c6e3ab-1873-40b7-b948-24526c7aa001)

Company: https://www.keypedia.com/companies/eagle-pharma-outsourcing-llc/6edf52f8-9dfe-4bca-b1d1-4f6da167361f

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea